Global Enteric Disease Testing Market: Snapshot
Enteric diseases are gastrointestinal infections caused by microbes such as bacteria, viruses, and parasites when they enter the body through the mouth or intestinal systems. Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio, and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as abdominal cramps, bloody diarrhea, stool containing blood or pus, fever, and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases need to be diagnosed early.
The global enteric disease testing market was valued at US$3.7 bn in 2017 and is likely to rise to US$4.9 bn by 2025, exhibiting a steady 3.6% CAGR therein.
Bacterial Enteric Diseases to Dominate Demand from Global Market
The global market for enteric disease testing has been segmented broadly on the basis of different pathogens causing enteric illness, namely bacteria, viruses, and parasites. The market is further segmented into various diseases caused by respective pathogens, such as salmonellosis, shigellosis, and campylobacteriosis, caused by enteric bacteria. Leading viral and parasitic enteric diseases include norovirus and rotavirus infections, giardiasis, amebiasis, and cryptosporidiosis. Key testing methods in the global enteric disease testing market include immunoassay testing, conventional testing, and molecular diagnostic testing. Further, the market has been segmented according to end use into hospitals, diagnostic laboratories, and physician offices.
Based on disease indication, bacterial enteric diseases accounted for approximately 58.5% of the global enteric disease testing market in 2016. Product developments that enable smooth and fast procedures for both physicians and patients and the growing incidence of diseases associated with E. coli and C. difficile are expected to fuel the growth of the bacterial enteric disease segment. The parasitic enteric disease segment is the second leading revenue generator for the global enteric disease testing market. In developed regions, frequent traveling to developing nations has become a major factor driving the segment’s growth.
Failure to Capitalize on High Potential of Asia Pacific Market could Cost Enteric Disease Testing Market Players
By geography, the global enteric disease testing market has been divided into five major regions: North America, Europe, Asia, Latin America, and the Middle East and Africa. North America and Europe accounted for the highest share of the global enteric disease testing market in 2017, followed by Asia Pacific, Latin America, and the Middle East and Africa. The U.S. dominated the enteric disease testing market in North America, accounting for around 94.0% of the latter in 2016. This dominance is majorly due factors such as high costs of products and high level of consumer awareness. The enteric disease testing market was valued at more than US$1 bn in both North America and Europe in 2017 and is likely to rise to more than US$1.4 bn by 2025, with Europe leading the way with a robust 4.7% CAGR.
Asia Pacific, accounting for more than 50% of the total global population, represents a profitable market for enteric disease testing in terms of growth and potential. The region is associated with unsafe drinking water, poor sanitation, and unhygienic conditions, and thus witnesses a large percentage of population infected with enteric microbes. The market for enteric disease testing is primarily driven in this region due to the high prevalence of enteric infections, rising awareness, inception of rapid diagnostic tests and continuously improving economy of India and China, leading to increased healthcare expenditure.
The key players operating in the enteric disease testing market are Trinity Biotech plc, Biomerica, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Biomerieux SA, Meridian Bioscience Inc., CorisBioconcept SPRL, Quest Diagnostics Incorporated, Cepheid Inc., and DiaSorin.
Global Enteric Disease Testing Market: Overview
This report on enteric disease testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing test kits for enteric disease testing as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global enteric disease testing market with respect to the leading market segments based on disease indication, testing methods, end-user, and geographies.
Global Enteric Disease Testing Market: Segmentation
Based on disease indication, the enteric disease testing market has been majorly segmented into: bacterial enteric disease, viral enteric disease, and parasitic enteric disease. Bacterial enteric disease includes segments such as C.difficile Infection, campylobacteriosis, cholera, E.coli infection, H.pylori infection, salmonellosis, and shigellosis. Viral enteric disease includes rotavirus infection and norovirus infection. Parasitic enteric disease includes amebiasis, cryptosporidiosis and giardiasis. In terms of testing methods, the enteric disease testing market has been broadly classified into immunoassay testing, conventional testing, and molecular diagnostic testing. In terms of end-users, the enteric disease testing market has been broadly classified into hospitals, diagnostic laboratories, and physician offices.
Global Enteric Disease Testing Market: Research Methodology
Each of the market segments have been extensively analyzed based on the market related factors such as incidence and prevalence of enteric bacterial infection and rise in application of molecular diagnostics for enteric disease testing. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the enteric disease testing market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global enteric disease testing market.
Global Enteric Disease Testing Market: Geographical and Competitive Dynamics
Geographically, enteric disease testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global enteric disease testing market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global enteric disease testing market. The report also profiles key players operating in the enteric disease testing market which are Trinity Biotech plc, Biomerica, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Biomerieux SA, Meridian Bioscience Inc., CorisBioconcept SPRL, Quest Diagnostics Incorporated, Cepheid Inc., DiaSorin and other prominent companies.
The global enteric disease testing market is segmented as follows:
Global Enteric Disease Testing Market, by Disease Indication
- Bacterial Enteric Disease
- C.difficile Infection
- E.coli Infection
- H.pylori Infection
- Viral Enteric Disease
- Rotavirus Infection
- Norovirus Infection
- Parasitic Enteric Disease
Global Enteric Disease Testing Market, by Testing Methods
- Immunoassay Testing
- Conventional Testing
- Molecular Diagnostic Testing
Global Enteric Disease Testing Market, by End-user
- Diagnostic Laboratories
- Physician Offices
Global Enteric Disease Testing Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia
- Latin America (LATAM)
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa